Trial intelligence / Profile preview

Effect of adalimumab on immune markers in lesional psoriatic skin

2008-001952-32Phase 4Completed

Sponsor: Radboud University Medical Center
Start: Oct 2008
Modality: Monoclonal Antibodies → Antibody-Based Therapeutics
Countries: 1

Overview

Phase 4, open-label, single-arm trial of adalimumab in plaque psoriasis, sponsored by Radboud University Medical Center. Primary endpoints: Psoriasis Area and Severity Index (PASI) score over time and Cell biological parameters in lesional skin. Started Oct 2008; status: completed.

Drugs

adalimumab

Conditions

plaque psoriasis

Beyond the preview

Go deeper on 2008-001952-32.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-001952-32.